Trulieve Cannabis opened lower at $11.11, compared with its previous close of $11.23. In the last trading session, the stock traded between $10.56 and $11.13. It showed a sideways intraday trend.
Return calculator
Time Period
An investment of $100 made 1 year ago in Trulieve Cannabis is now worth
$ 97.12
Resulting in a loss of
$ 2.88 (2.88%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 3 Analysts
Buy
100%
Hold
0%
Sell
0%
Markets Today
Today's Change
$-0.06 (-0.54%)
Day High
$11.13
Day Low
$10.56
Day Open
$11.11
Prev Close
$11.23
Volume
13,47,358
1W Return
-3.47%
1M Return
7.37%
3M Return
20.07%
6M Return
-2.88%
1Y Return
-2.88%
Fundamentals
Market Cap ($ Mn)
1,901
PE Ratio
-
PB Ratio
2.96
PEG Ratio
-
ROE
-9.59%
ROCE
5.14%
EPS (TTM)
$-0.29
Investment Returns
1 Week
-3.47%
1 Month
7.37%
3 Months
20.07%
6 Months
-2.88%
9 Months
-2.88%
Financials
Quarterly
All values in $ Mn
284.3
Sep 24
301.1
Dec 24
297.8
Mar 25
302.1
Jun 25
288.2
Sep 25
293.1
Dec 25
Updates
6Nov
Trulieve Q3FY26 Results: Adj EPS $0.09 beats $0.07 est, sales down 20% YoY
Adjusted EPS of $0.09 beat consensus estimate of $0.07 by 28.57%. Quarterly sales of $230.000 million exceeded estimates by 3.66%. Sales declined 20.14% YoY from $288.000 million in prior year. Gross margin held at 64%, with adjusted EBITDA at $89 million. Secured DEA registrations enabling removal of 280E tax burden.
7 days ago
2Nov
Trulieve Cannabis secures initial DEA registrations for dispensaries
Trulieve Cannabis Corp. received federal registrations for its medical marijuana dispensaries from the U.S. Drug Enforcement Administration. The registrations are part of the initial issuance to qualifying state-licensed businesses following the Attorney General's April order. Trulieve applied for registration in April after state-licensed medical marijuana was rescheduled to Schedule III.